1. EachPod
EachPod

Dupilumab for Severe Pediatric Atopic Dermatitis

Author
HCPLive.com
Published
Sat 04 Apr 2020
Episode Link
https://audioboom.com/posts/7548153

Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Share to: